TABLE 3.
MIC (mg/liter) | Cefepime dosing regimena at the following creatinine clearance (ml/min): |
||||
---|---|---|---|---|---|
10–30 | >30–60 | >60–90 | >90–120 | >120–150 | |
1 | 2 g q12h (II) | 2 g q12h (II) | 2 g q8h (II) | 2 g q8h (II) | 2 g q8h (EI) |
2 | 2 g q12h (II) | 2 g q8h (II) | 2 g q8h (II) | 2 g q8h (EI) | 6-g CI |
4 | 2 g q12h (II) | 2 g q8h (II) | 2 g q8h (EI) | 7- to 8-g CI | 8-g CI |
8 | 2 g q8h (II) | 2 g q8h (EI) | 2 g q6h (EI) | 4-g LD, 6-g CI | 4-g LD, 7-g CI |
16 | 2 g q6h (II) | 4-g LD, 6-g CI | 4-g LD, 6-g CIb | 4-g LD, 8-g CIb | 4-g LD, 8-g CIb |
CI, continuous infusion; EI, extended infusion over half the dosing interval; II, intermittent infusion over 30 min; LD, loading dose over 4 h.
Target attainment between 80% and 90%.